APOE and Alzheimer disease: The presence of ApoE4 contributes to exacerbated clinical outcomes in the 5XFAD models, as together they exacerbate some of the pathological clinical aspects of AD, such as an increase in amyloid-beta load, a significant progression of cognitive decline, and impaired neuronal communication [44].